Dr. Andreas A Linninger's research lab focuses on understanding how age and Alzheimer's disease affect blood flow and metabolism in the brain. By using advanced imaging techniques and computational modeling, the lab aims to create detailed simulations linking changes observed in mouse models to conditions in humans. This research seeks to identify biomarkers that could predict cognitive decline and improve diagnostic methods for Alzheimer’s disease.

The research lab led by Hanzhang Lu at Johns Hopkins University focuses on understanding the vascular contributions to cognitive impairment and dementia, particularly small-vessel-related conditions. They work on developing and validating biomarkers that can help in the diagnosis and treatment of various types of dementia, including Alzheimer's disease. Their pioneering work includes using advanced MRI techniques to measure brain physiology, aiming to improve patient care through better diagnostic tools.

Dr. Mitsue Miyazaki's lab at UC San Diego focuses on understanding how cerebrospinal fluid (CSF) drainage affects cognitive function, particularly in aging and Alzheimer's disease. The research aims to develop new non-invasive MRI techniques to measure CSF outflow and its connection to cognitive decline and physical activity. By studying these mechanisms, the lab hopes to contribute to early diagnosis and intervention strategies for neurodegenerative diseases.

Dr. Zhiliang Wei's lab at Johns Hopkins University focuses on understanding how reduced blood flow in the brain, known as hypoperfusion, affects Alzheimer's disease and related dementias. By using advanced MRI techniques and mouse models, the lab aims to explore how blood flow interacts with brain metabolism and cognitive functions. This research is crucial for identifying new biomarkers and treatments for dementia, enhancing the understanding of the disease mechanisms.

Dr. Surbhi Grover's lab at the University of Pennsylvania focuses on improving cancer care in low- and middle-income countries, with a specific emphasis on addressing delays in treatment for cervical cancer in Botswana. The research seeks to identify practical strategies that enable timely treatment after diagnosis by analyzing barriers and enhancing communication and care coordination. Through innovative study designs, the lab aims to create sustainable solutions that improve health outcomes for women facing cervical cancer, especially in contexts with high HIV prevalence.

Dr. Hua Li's research focuses on improving the treatment of cervical cancer by utilizing advanced imaging techniques and RNA analyses. The goal is to develop personalized treatment strategies by predicting how well individual tumors will respond to therapy. The lab combines data from various sources, such as imaging and genetic information, to create robust models that can aid in clinical decision-making and improve patient outcomes.

Dr. Jin Zhang's lab at Washington University focuses on improving treatment outcomes for cervical cancer patients by developing predictive biomarkers and understanding the biology behind treatment resistance. Their research combines genomics and imaging techniques to identify patients at risk of treatment failure and to detect cancer recurrence early using advanced analytical methods. By integrating multi-omics data, the lab aims to personalize cancer therapy and enhance patient care.

Dr. Julie Kristina Schwarz's lab focuses on improving radiation therapy for cervical cancer by targeting the metabolism of glutamine, an amino acid crucial for cancer cell growth. The research aims to enhance anti-tumor immunity and increase the effectiveness of radiation treatment by combining it with a drug that inhibits glutamine metabolism. Through both laboratory studies and clinical trials, the lab works to develop innovative strategies for treating radiation-resistant cervical cancers.

Evan Alexander Scott's lab at the University of Virginia focuses on developing innovative nanotherapeutic strategies to tackle chronic Chagas disease, particularly its associated heart condition, chronic Chagas cardiomyopathy (CCC). The lab aims to create treatments that not only reduce inflammation and cardiac damage but also target the parasite's reservoirs within the body. By optimizing drug delivery systems and minimizing toxicity, the lab seeks to provide effective therapies for patients battling this neglected tropical disease.

Dr. Ganesh Chand's lab focuses on understanding Alzheimer's disease and its effects on brain function and behavior. Using advanced machine learning techniques, the lab studies the relationships between brain imaging markers, neuropsychiatric symptoms, and genetic factors in Alzheimer's patients and healthy controls. The goal is to uncover how different biological markers correlate with symptoms and identify distinct subgroups of patients, ultimately aiding in more personalized treatment approaches for the disease.

The lab led by Dr. Akshay Chaudhari at Stanford University focuses on improving cardiovascular disease risk prediction using advanced deep learning techniques. By analyzing existing abdominal CT scans and electronic medical records, the lab aims to develop new algorithms that enhance the accuracy of risk assessments for conditions such as heart attacks and strokes. Their work not only seeks to refine traditional prediction methods but also to promote health equity by ensuring accurate evaluation across diverse populations.

Dr. Abhijit J Chaudhari's lab focuses on understanding and improving the treatment of myofascial pain syndrome, a common condition that causes significant discomfort to many individuals. The lab is working on establishing innovative imaging techniques using Total-body PET/CT to identify and measure key aspects of muscle and tissue health related to myofascial pain. This research aims to provide medical professionals with better tools for evaluating the effectiveness of pain treatments and enhance patient care.

Dr. Chi-Hua Chen's lab at UC San Diego focuses on uncovering how genetic factors influence brain structure and their relation to neuropsychiatric disorders. The research employs advanced brain imaging techniques like MRI and analyzes genetic data to identify links between specific genetic variants and brain morphology. By creating genetic atlases of the human cortex, the lab aims to enhance our understanding of how genetics can shape the brain and contribute to conditions such as depression and anxiety.

Dr. Wei Chen's lab focuses on developing advanced imaging techniques to study how energy metabolism in the brain changes in different health conditions. They use cutting-edge magnetic resonance imaging (MRI) tools to explore how brain energy production and metabolism are affected by aging, neurological disorders, and tumors. The goal is to create non-invasive methods that can help us better understand and diagnose brain diseases.

Dr. Timothy C. Zhu's lab at the University of Pennsylvania focuses on improving cancer treatment through advanced imaging techniques. The lab is developing Cherenkov imaging, which uses light emitted from tissue during radiation therapy to create real-time maps of the radiation dose delivered to patients' skin. This innovative approach aims to enhance the precision of total skin electron therapy (TSET) for patients suffering from conditions like mycosis fungoides, ensuring that they receive the correct dose and improving treatment outcomes.

Dr. Thomas M Ernst's lab at the University of Maryland Baltimore is focused on understanding how brain development occurs during childhood and adolescence. Through the Adolescent Brain Cognitive Development (ABCD) Study, the lab investigates how different life experiences, such as sports or substance use, can influence cognitive and emotional growth in children. The research involves long-term tracking of diverse participants to identify factors that contribute to both healthy brain development and risks for mental health issues.

Dr. Weili Lin's lab focuses on understanding how various environmental factors, particularly during prenatal and early childhood periods, affect child development. This work is part of a large scale study involving thousands of mothers and infants, aiming to track developmental changes while assessing the effects of substances such as opioids and alcohol. The findings from this research will help shape public health policies to support child health across the U.S.

Dr. Claude B. Sirlin's lab at UC San Diego focuses on developing better ways to diagnose nonalcoholic fatty liver disease (NAFLD) in children using quantitative ultrasound. With over 5 million American children affected by NAFLD, this research is crucial for early diagnosis and treatment. The lab aims to create more accurate and accessible diagnostic tools that can be widely used to improve pediatric health outcomes.

Dr. Rebecca Maureen Howell's lab focuses on improving the health outcomes of childhood cancer survivors, particularly in reducing the risk of cardiovascular disease. The lab is working on creating advanced models to predict cardiovascular risks based on specific doses of radiation received during cancer treatment. By personalizing risk assessments, they aim to improve both current treatment planning and future healthcare strategies for survivors.

Dr. Yan Li's lab at the University of California, San Francisco focuses on understanding and improving cognitive functioning and quality of life for patients with lower grade astrocytoma. They use advanced MRI techniques to assess how tumors and their treatment impact brain function. The research aims to develop better clinical strategies for patient management and treatment therapy based on their findings.